Press & Blog

November 12, 2015
Guest blogger Dr. Anna Barker announces the design and plan for the GBM AGILE trial. This trial represents the first global initiative created by a groundbreaking global coalition of some of the world’s leading GBM neuro-surgeons, neuro-oncologists, and clinical investigators and researchers. The GBM AGILE trial will be a learning system, where a patient’s individualized response to specific treatments will inform the ongoing direction of the trial.
November 11, 2015
Last month, our friends went to extremes to raise funds and awareness in three ABC2-sponsored events: Crossing the Canyon, Over The Edge San Diego and the Marine Corps Marathon.
Press Releases
November 2, 2015
ABC² (Accelerate Brain Cancer Cure), the Pediatric Brain Tumor Foundation and the BraveCort Foundation are working together to fund the development of immunosignature-based blood tests for detecting, classifying and monitoring pediatric medulloblastoma over time.
October 27, 2015
ABC² joined with 70 other disease organizations to voice our support of Dr. Califf’s nomination to become the next FDA commissioner. The Senate hearing for Califf, currently a deputy commissioner at the Food and Drug Administration and a longtime researcher at Duke University, was held on November 17th, but a confirmation vote has not been set.